Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives from (a) GPs, (b) patient organisations and (c) manufacturers on the availability of the new enhanced influenza vaccine for the over-65s for the 2017-18 and the 2018-19 season.

Officials at the Department and Public Health England have regular discussions with manufacturers on a range of issues. This has included discussion with Seqirus, the company that has produced the new adjuvanted trivalent flu vaccine (aTIV).

Officials have had no discussions with general practitioner representatives or patient groups on the aTIV.

Officials also attend meetings of the Joint Committee on Vaccination and Immunisation, which includes a lay member.